THE COMBINATION OF VENETOCLAX AND FTY720 HAS A SYNERGISTIC PRO-APOPTOTIC EFFECT IN ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Irene, Peris [1 ]
Elena, Martinez-Balsalobre [2 ]
Elena, Arriazu [3 ]
Silvia, Romero-Murillo [1 ]
Javier, Marco [1 ]
Nerea, Marcotegui [4 ]
Andrea, Torres-Lopez [5 ]
Carmen, Mateos M. [5 ]
Luisa, Cayuela M. [2 ]
Dolores, Odero M. [1 ]
Carmen, Vicente [1 ]
机构：
[1] Univ Navarra, Pamplona, Spain
[2] Inst Murciano Invest Biosanitaria, Murcia, Spain
[3] Inst Salud Carlos III, Madrid, Spain
[4] CIMA Univ Navarra, Pamplona, Spain
[5] Complejo Hosp Navarra, Pamplona, Spain
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
CO-071
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [31] Venetoclax-Based Combination Regimens in Acute Myeloid Leukemia
    Goulart, Hannah
    Kantarjian, Hagop
    Pemmaraju, Naveen
    Daver, Naval
    Dinardo, Courtney D.
    Rausch, Caitlin R.
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD CANCER DISCOVERY, 2025, 6 (01): : 23 - 37
  • [32] Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia
    Brancati, Serena
    Gozzo, Lucia
    Romano, Giovanni Luca
    Vetro, Calogero
    Dulcamare, Ilaria
    Maugeri, Cinzia
    Parisi, Marina
    Longo, Laura
    Vitale, Daniela Cristina
    Di Raimondo, Francesco
    Drago, Filippo
    BLOOD, 2021, 138
  • [33] Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes
    Shimony, Shai
    Stone, Richard M.
    Stahl, Maximilian
    CURRENT OPINION IN HEMATOLOGY, 2022, 29 (02) : 63 - 73
  • [34] Venetoclax efficacy on acute myeloid leukemia is enhanced by the combination with butyrate
    Renshi Kawakatsu
    Kenjiro Tadagaki
    Kenta Yamasaki
    Tatsushi Yoshida
    Scientific Reports, 14
  • [35] Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides
    Sioud, Mouldy
    Pettersen, Solveig
    Ailte, Ieva
    Floisand, Yngvar
    CANCERS, 2019, 11 (08)
  • [36] Oral fingolimod (FTY720), 0.5 or 1.25 mg, for 14 days has no effect on cardiac function
    Schmouder, Robert
    Liu, Cherrie
    David, Oliver J.
    Wang, Nan
    MULTIPLE SCLEROSIS, 2008, 14 : S177 - S177
  • [37] New Insights into the Structural Requirements of Isatin-Derived Pro-Apoptotic Agents against Acute Myeloid Leukemia
    Hamdy, Ahmed K. K.
    Sakamoto, Takashi
    Toma, Tsugumasa
    Sakamoto, Masaharu
    Abourehab, Mohammed A. S.
    Otsuka, Masami
    Fujita, Mikako
    Tateishi, Hiroshi
    Radwan, Mohamed O. O.
    PHARMACEUTICALS, 2022, 15 (12)
  • [38] FTY720, a novel immunosuppressant possessing unique mechanisms .1. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats
    Chiba, K
    Hoshino, Y
    Suzuki, C
    Masubuchi, Y
    Yanagawa, Y
    Ohtsuki, M
    Sasaki, S
    Fujita, T
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (02) : 1056 - 1059
  • [39] Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation
    Xu, M
    Antoniou, EA
    Afford, SC
    Suzuki, S
    Pirenne, J
    McMaster, P
    DSilva, M
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (07) : 2964 - 2966
  • [40] Venetoclax in combination with azacitidine or decitabine in relapsed/refractory acute myeloid leukemia
    Che, Yue
    Tan, Wanqing
    Liu, Ying
    Liu, Haitao
    Li, Lanlan
    Qin, Fangmei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 209 - 214
12345